Raymond M. Esper

1.2k total citations · 1 hit paper
12 papers, 976 citations indexed

About

Raymond M. Esper is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Raymond M. Esper has authored 12 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Raymond M. Esper's work include Axon Guidance and Neuronal Signaling (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Raymond M. Esper is often cited by papers focused on Axon Guidance and Neuronal Signaling (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Raymond M. Esper collaborates with scholars based in United States, Canada and Türkiye. Raymond M. Esper's co-authors include Jeffrey A. Loeb, Douglas L. Falls, Steven Einheber, Xiaorong Xu, Carla Taveggia, Hiroko Yano, Moses V. Chao, Lorna W. Role, Peter Shrager and James L. Salzer and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Clinical Oncology.

In The Last Decade

Raymond M. Esper

12 papers receiving 965 citations

Hit Papers

Neuregulin-1 Type III Determines the Ensheathment Fate of... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers

Raymond M. Esper
Ivan Selak Bosnia and Herzegovina
Luis F. Parada United States
Carol Wuenschell United States
David Trisler United States
Marie C. Harrisingh United Kingdom
Milan Makwana United Kingdom
Ivan Selak Bosnia and Herzegovina
Raymond M. Esper
Citations per year, relative to Raymond M. Esper Raymond M. Esper (= 1×) peers Ivan Selak

Countries citing papers authored by Raymond M. Esper

Since Specialization
Citations

This map shows the geographic impact of Raymond M. Esper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond M. Esper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond M. Esper more than expected).

Fields of papers citing papers by Raymond M. Esper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond M. Esper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond M. Esper. The network helps show where Raymond M. Esper may publish in the future.

Co-authorship network of co-authors of Raymond M. Esper

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond M. Esper. A scholar is included among the top collaborators of Raymond M. Esper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond M. Esper. Raymond M. Esper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Riely, Gregory J., Egbert F. Smit, Myung‐Ju Ahn, et al.. (2023). Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAFV600E) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study.. Journal of Clinical Oncology. 41(16_suppl). 9018–9018. 1 indexed citations
2.
Esper, Raymond M., Ananda Sen, B Simon, et al.. (2019). Dietary polyunsaturated fatty acids modulate adipose secretome and is associated with changes in mammary epithelial stem cell self-renewal. The Journal of Nutritional Biochemistry. 71. 45–53. 6 indexed citations
3.
Esper, Raymond M., Michael K. Dame, Shannon D. McClintock, et al.. (2015). Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells. Cancer Prevention Research. 8(12). 1174–1183. 27 indexed citations
4.
Esper, Raymond M. & Jeffrey A. Loeb. (2009). Neurotrophins Induce Neuregulin Release through Protein Kinase Cδ Activation. Journal of Biological Chemistry. 284(39). 26251–26260. 35 indexed citations
6.
Esper, Raymond M., et al.. (2006). Neuregulins: Versatile growth and differentiation factors in nervous system development and human disease. Brain Research Reviews. 51(2). 161–175. 126 indexed citations
7.
Taveggia, Carla, George Zanazzi, Hiroko Yano, et al.. (2005). Neuregulin-1 Type III Determines the Ensheathment Fate of Axons. Neuron. 47(5). 681–694. 562 indexed citations breakdown →
8.
Esper, Raymond M. & Jeffrey A. Loeb. (2004). Rapid Axoglial Signaling Mediated by Neuregulin and Neurotrophic Factors. Journal of Neuroscience. 24(27). 6218–6227. 75 indexed citations
9.
Li, Qunfang, Raymond M. Esper, & Jeffrey A. Loeb. (2004). Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression. Molecular and Cellular Neuroscience. 26(4). 558–569. 14 indexed citations
10.
Dijkers, Marcel, et al.. (2002). Quality of Intervention Research Reporting in Medical Rehabilitation Journals. American Journal of Physical Medicine & Rehabilitation. 81(1). 21–33. 42 indexed citations
11.
Dijkers, Marcel, et al.. (2002). Reporting on reliability and validity of outcome measures in medical rehabilitation research. Disability and Rehabilitation. 24(16). 819–827. 42 indexed citations
12.
Worth, Randall G., Raymond M. Esper, Andrei L. Kindzelskii, et al.. (2001). Mercury Inhibition of Neutrophil Activity: Evidence of Aberrant Cellular Signalling and Incoherent Cellular Metabolism. Scandinavian Journal of Immunology. 53(1). 49–55. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026